Active ingredientArbekacinCat. No. P-A181-001CAS 51025-85-5Family · Pharmaceutical analytical standards
Arbekacin
A semi-synthetic aminoglycoside antibiotic derived from dibekacin, synthesised in 1973 and first marketed in Japan in 1990 for pneumonia and sepsis caused by methicillin-resistant Staphylococcus aureus (MRSA). This family brings together the active ingredient.
Did you know?It was created in the group of Hamao Umezawa, the Japanese microbiologist who had already discovered the antibiotic kanamycin and the anticancer drug bleomycin.
Go to the active ingredient →Active ingredientArbekacinCat. No. P-A181-001CAS 51025-85-5
Active ingredientArbekacin SulfateCat. No. P-A181-002CAS 104931-87-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.